von BOETTICHER Rechtsanwälte Partnerschaftsgesellschaft mbB is renowned for their work for pharmaceutical and life sciences companies, bringing expertise in drug advertising, patent, IP and copyright law to a range contentious matters and transactions. These include medical insolvency proceedings, contract negotiations, advice on the launching of new healthcare products, and the acquisition and management of portfolios. Claudia Böhm and Anselm Brandi-Dohrn lead on matters of advertising law and licensing agreements respectively.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Client satisfaction: Sector knowledge
Key clients
- Acino Group
- Bavarian-Nordic GmbH
- Betterguards GmbH
- BioXXmed AG
- CellAct Pharma GmbH
- EVER Neuro Pharma GmbH/EVER Pharma GmbH/EVER Valinject GmbH
- Gilead Sciences GmbH
- LEO Pharma GmbH
- Lipotype GmbH
- Madaus & Lauscher GmbH
- Maskawaan Group, Hongkong
- Nekonal S.a.r.l.
Work highlights
Represented a research-based, international pharmaceutical company in large number of disputes with a competitor in the field of influenca vaccines.
Represented Gilead before the courts concerning a new medicinal product aimed at treating PBC.
Represented Bavarian Nordic A/S before the courts concerning a new vaccine against the Chikungunya virus.
Practice head
Claudia Böhm; Anselm Brandi-Dohrn